학술논문
O-011 Modified FOLFOXIRI (mFOLFOXIRI) plus cetuximab (cet), followed by cet or bevacizumab (bev) maintenance, in RAS/BRAF wt metastatic colorectal cancer (mCRC): results of the phase II randomized MACBETH trial by GONO
Document Type
Article
Author
Source
In Annals of Oncology June 2016 27 Supplement 2:ii121-ii121
Subject
Language
ISSN
0923-7534